跳至主要内容
临床试验/NCT02077127
NCT02077127已完成不适用

Association of Monocyte Chemoattractant Protein-1 (MCP-1)2518A/G Polymorphism With Proliferative Diabetic Retinopathy in Northern Chinese Type 2 Diabetes

Harbin Medical University1 个研究点 分布在 1 个国家目标入组 1,043 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,043
试验地点
1
主要终点
Genetic association

研究概览

简要总结

The pathogenesis of proliferative diabetic retinopathy (PDR) remains poorly understood. Recent studies have implicated that monocyte chemoattractant protein-1 (MCP-1) is associated with diabetic microvascular or macrovascular complications. However, the relationship between SNP polymorphism c.2518A/G in the MCP-1 gene with diabetic retinopathy remains controversial. In the present study, we evaluated the association of a single nucleotide polymorphism (SNP) in the MCP-1 gene with diabetic retinopathy (DR) and diabetic macular edema (DME) in Chinese population from Southern China with type 2 diabetes.

详细描述

The association between polymorphism of MCP-1 c.2518A/G and DR had been reported in Japan and Korea, but their opinion were inconsistent. However there is no report in China so far. This study was designed to clarify the relationship of polymorphism of MCP-1 c.2518A/G with type 2 diabetes with or without DR. The relationship between MCP-1 c.2518A/G and different stage of DR has also been studied.This article proved that the MCP-1 c.2518G/G genotype is a susceptibility gene for DR in Chinese type 2 diabetic patients, especially the High-risk PDR. There is no association with DME and c.2518G/G.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
41 Years 至 68 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetic retinopathy
  • age at diagnosis ≥30 years and a known duration of diabetes of ≥5 years.

排除标准

  • eyeball atrophy
  • epimacular membrane
  • age-related macular degeneration (ARMD)
  • intravitreal injection medicine
  • vitreous hemorrhage

结局指标

主要结局

Genetic association

时间窗: 1 year

age at diagnosis of diabetes ≥30 years and a known duration of diabetes of ≥5 years.

次要结局

未报告次要终点

研究者

发起方
Harbin Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Li Dong

Li Dong

Harbin Medical University

研究点 (1)

Loading locations...

相似试验